梅花生物(600873.SH):2名董事及高管擬減持不超43.5萬股
格隆匯5月21日丨梅花生物(600873.SH)公佈,樑宇博為公司董事、副總經理,目前持有公司股票5486.85萬股,佔公司總股本的1.77%,其中5366.85萬股為發行股份購買資產取得的股票;120萬股為公司2018年限制性股票激勵計劃授予的限制性股票,其中36萬股已於2019年7月18日解除限售。其通過發行股份購買資產取得的股票不減持,僅減持2018年限制性股票激勵計劃授予的已解除限售的股份。
劉現芳為公司董事會祕書,目前持有公司股票30萬股,佔公司總股本的0.01%,為公司2018年限制性股票激勵計劃授予的限制性股票,其中9萬股已於2019年7月18日解除限售。
樑宇博、劉現芳擬採用集中競價交易方式減持公司2018年限制性股票激勵計劃第一個解除限售期已解除限售的部分股份,計劃將於公告披露之日起15個交易日後的6個月內,減持數量分別不超過其各自持有公司股份數量的25%,即不超36萬股及7.5萬股。若上述減持期間公司有送股、資本公積金轉增股本、配股等事項,減持股票數量將相應調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.